YDR230W is a protein-coding gene in Saccharomyces cerevisiae (baker's yeast), specifically identified in the standard reference strain ATCC 204508/S288c. Antibodies targeting this protein are valuable for studying its expression, localization, and functional interactions within cellular pathways. YDR230W antibodies enable researchers to investigate protein dynamics in response to environmental conditions, genetic modifications, or drug treatments. These antibodies serve as essential tools for characterizing protein functions in fundamental yeast cellular processes, contributing to our understanding of conserved eukaryotic mechanisms .
When selecting a YDR230W antibody, researchers should evaluate several technical specifications to ensure experimental success. The antibody should have verified reactivity with Saccharomyces cerevisiae strain ATCC 204508/S288c. Key specifications include:
| Specification | Details for YDR230W Antibody |
|---|---|
| Product Code | CSB-PA777428XA01SVG |
| UniProt Accession | A0A023PZA9 |
| Target Species | Saccharomyces cerevisiae (strain ATCC 204508/S288c) |
| Available Sizes | 2ml/0.1ml |
| Format | Purified immunoglobulin |
| Applications | Western blotting, immunoprecipitation, immunofluorescence (application-specific protocols recommended) |
Additionally, researchers should consider whether the antibody has been validated for their specific experimental conditions, including detection method compatibility and cross-reactivity profiles .
Proper storage and handling of YDR230W antibodies are critical for maintaining reactivity and specificity. Store antibodies at -20°C for long-term preservation and at 4°C for short-term use (generally 1-2 weeks). Avoid repeated freeze-thaw cycles by preparing small aliquots upon initial thawing. When handling, maintain sterile conditions and use nuclease-free, low-protein binding tubes. For optimal stability, consider adding protein stabilizers such as BSA (0.1-1%) to diluted antibody preparations. Before each use, centrifuge the antibody vial briefly to collect all material at the bottom of the tube. Document lot numbers and reception dates to track antibody performance over time. Always validate new lots against previous ones before conducting critical experiments .
For optimal Western blotting with YDR230W antibodies, follow this methodological approach:
Sample preparation: Extract yeast proteins using mechanical disruption (glass beads) in the presence of protease inhibitors. Include phosphatase inhibitors if investigating post-translational modifications.
Electrophoresis conditions: Separate 20-50 μg total protein on 10-12% SDS-PAGE gels. For higher molecular weight proteins, consider using gradient gels (4-15%).
Transfer parameters: Transfer to PVDF membranes (preferred over nitrocellulose for yeast proteins) at 100V for 60-90 minutes in standard Towbin buffer with 20% methanol. For larger proteins, extend transfer time or reduce voltage.
Blocking conditions: Block with 5% non-fat dry milk in TBS-T for 1 hour at room temperature. For phospho-specific detection, substitute with 5% BSA.
Antibody incubation: Dilute YDR230W antibody 1:500 to 1:2000 in blocking buffer. Incubate overnight at 4°C with gentle rocking. Wash 4 times with TBS-T, 5 minutes each.
Detection strategy: Use HRP-conjugated secondary antibodies (1:5000-1:10000) for 1 hour at room temperature. For low abundance proteins, consider enhanced chemiluminescence substrates or fluorescent secondary antibodies.
Controls: Always include a lane with lysate from a YDR230W knockout strain as a negative control. Consider including a positive control with overexpressed tagged YDR230W .
For successful immunoprecipitation (IP) of YDR230W from yeast lysates, implement the following methodological framework:
Lysis optimization: Prepare yeast lysates using gentle lysis buffers (e.g., 50 mM Tris-HCl pH 7.5, 150 mM NaCl, 0.5% NP-40, 1 mM EDTA with protease inhibitors). For membrane-associated proteins, include 1% digitonin or 0.5% CHAPS.
Pre-clearing: Pre-clear lysates with protein A/G beads for 1 hour at 4°C to reduce non-specific binding.
Antibody coupling: For direct IP, add 2-5 μg of YDR230W antibody to 500 μg-1 mg of pre-cleared lysate and incubate with rotation overnight at 4°C. Alternatively, pre-couple the antibody to protein A/G beads for 2-4 hours before adding to lysate.
Washing stringency: Perform 4-5 washes with decreasing salt concentrations (from 300 mM to 150 mM NaCl) to remove non-specific interactions while preserving specific ones.
Elution strategies: Elute using acidic conditions (0.1 M glycine, pH 2.5) for downstream applications requiring native protein, or directly with SDS sample buffer for Western blot analysis.
Validation approach: Confirm specificity by parallel IP with an isotype control antibody and by immunoblotting the immunoprecipitated material with a second antibody recognizing a different epitope of YDR230W .
For optimal immunofluorescence localization of YDR230W in yeast cells, implement these methodological modifications:
Fixation protocol: Fix mid-log phase yeast cells with 4% formaldehyde for 1 hour, followed by treatment with Zymolyase 100T (100 μg/ml) for 30 minutes at 30°C to digest the cell wall while preserving cellular architecture.
Permeabilization optimization: After spheroplasting, permeabilize with 0.2% Triton X-100 for 10 minutes. For proteins with weak signals, extend permeabilization time to 15 minutes or increase detergent concentration to 0.5%.
Blocking parameters: Block with 3% BSA in PBS containing 0.1% Tween-20 for 1 hour at room temperature to minimize non-specific binding.
Antibody concentration: Use YDR230W antibody at 1:100 to 1:250 dilution for primary incubation (overnight at 4°C). For weaker signals, use signal amplification systems such as tyramide signal amplification.
Mounting considerations: Mount with anti-fade mounting medium containing DAPI for nuclear counterstaining. For multi-channel imaging, use spectral unmixing to address yeast autofluorescence issues in the green channel.
Controls: Include appropriate controls such as cells from YDR230W deletion strains, peptide competition experiments, and secondary antibody-only controls .
To rigorously validate YDR230W antibody specificity, implement a multi-faceted approach:
Genetic controls: Test the antibody against lysates from YDR230W deletion strains in parallel with wild-type strains. The signal should be absent or significantly reduced in deletion strains.
Epitope mapping: Perform epitope mapping using recombinant fragments or synthetic peptides to verify the exact binding region of the antibody, which helps predict potential cross-reactivity.
Immunodepletion: Pre-absorb the antibody with recombinant YDR230W protein before immunostaining or Western blotting. This should eliminate specific staining if the antibody is truly targeting YDR230W.
Mass spectrometry validation: Immunoprecipitate with the YDR230W antibody and analyze the pulled-down proteins by mass spectrometry. YDR230W should be among the most abundant proteins identified.
Orthogonal approaches: Compare antibody results with orthogonal detection methods such as fluorescent protein tagging or CRISPR-mediated epitope tagging of the endogenous YDR230W.
Cross-strain comparison: Test antibody performance across different Saccharomyces cerevisiae strains to evaluate conservation of the epitope and potential strain-specific differences .
For optimizing YDR230W detection in challenging samples such as stationary phase yeast or complex genetic backgrounds, implement these advanced techniques:
Sample enrichment: For low abundance detection, enrich for subcellular fractions where YDR230W is predominantly localized before immunoblotting or immunoprecipitation.
Signal amplification: Utilize tyramide signal amplification (TSA) or poly-HRP detection systems to enhance sensitivity by 10-100 fold compared to conventional detection methods.
Epitope retrieval: For fixed samples with potential epitope masking, incorporate antigen retrieval steps such as heat-induced epitope retrieval (citrate buffer, pH 6.0, 95°C for 20 minutes) or enzymatic retrieval with proteases.
Alternative detergents: Test different detergent combinations (CHAPS, digitonin, or DDM) for extraction when standard lysis conditions yield poor results.
Proximity ligation assay: For detecting protein-protein interactions involving YDR230W, implement proximity ligation assays (PLA) which offer single-molecule sensitivity.
Crosslinking strategies: For transient interactions, incorporate reversible crosslinking (1-2% formaldehyde, 10 minutes at room temperature) before cell lysis .
When facing inconsistent results with YDR230W antibodies, apply this systematic troubleshooting framework:
Antibody quality assessment: Verify antibody integrity by dot-blotting serial dilutions. Loss of signal at expected dilutions may indicate antibody degradation.
Protocol parameter titration: Systematically vary key parameters (antibody concentration, incubation time, temperature) to identify optimal conditions for your specific experimental setup.
Buffer composition analysis: Test different buffer systems, particularly varying salt concentrations (100-300 mM) and detergent types/concentrations to optimize signal-to-noise ratio.
Protein modification impacts: Consider whether post-translational modifications affect epitope recognition. Test phosphatase treatment for phosphorylation-sensitive epitopes.
Batch variation documentation: Maintain detailed records of antibody lot numbers and corresponding performance to identify potential lot-to-lot variations.
Expression condition effects: Evaluate how different growth conditions (carbon source, growth phase, stress conditions) affect YDR230W expression and antibody recognition .
For successful chromatin immunoprecipitation using YDR230W antibodies, researchers should implement these specialized methodological considerations:
Crosslinking optimization: Titrate formaldehyde concentration (0.5-3%) and crosslinking time (10-30 minutes) to balance efficient crosslinking with epitope preservation. For proteins with indirect DNA interactions, consider using protein-protein crosslinkers like DSG before formaldehyde.
Sonication parameters: Optimize sonication conditions to generate chromatin fragments between 200-500 bp. Monitor fragmentation efficiency using agarose gel electrophoresis before proceeding with immunoprecipitation.
Antibody selection: Use ChIP-grade or ChIP-validated YDR230W antibodies when available. For untested antibodies, perform preliminary IP experiments to verify their ability to immunoprecipitate the native protein.
Controls implementation: Include mock IP (no antibody), isotype control antibody, and input samples as essential controls. For definitive validation, perform parallel ChIP experiments in YDR230W deletion or depletion strains.
Chromatin amount titration: Determine the optimal ratio of antibody to chromatin by testing different amounts of chromatin (25-100 μg) with a fixed amount of antibody.
Washing stringency gradient: Implement a gradient of washing stringency to identify conditions that maximize signal-to-noise ratio while maintaining specific interactions .
To effectively incorporate YDR230W antibodies into quantitative proteomics workflows, implement these methodological adaptations:
Sample preparation optimization: For IP-MS applications, use gentle lysis conditions that preserve protein complexes (150-300 mM salt, 0.1-0.5% NP-40 or digitonin).
SILAC integration: Combine antibody-based enrichment with SILAC labeling to accurately quantify YDR230W-associated proteins across different conditions. Grow yeast in heavy (Lys8, Arg10) or light (Lys0, Arg0) media before immunoprecipitation.
Crosslinking MS (XL-MS): For capturing transient interactions, implement protein crosslinking with MS-cleavable crosslinkers (e.g., DSSO) prior to immunoprecipitation with YDR230W antibodies.
PTM enrichment strategy: For studying post-translational modifications, combine YDR230W immunoprecipitation with subsequent enrichment of specific modifications (e.g., TiO₂ for phosphopeptides).
Quantification approach: Select appropriate MS1 or MS2-based quantification strategies based on the experimental question. Consider TMT labeling for multiplexed comparisons across multiple conditions.
Data analysis pipeline: Implement specialized software tools for analyzing protein-protein interaction networks (e.g., SAINT for significance analysis of interactomes) and interpreting dynamic changes in the YDR230W interactome .
To ensure robust and reproducible results with YDR230W antibodies, incorporate these essential experimental controls:
Genetic negative controls: Include samples from YDR230W deletion strains or strains with significantly reduced YDR230W expression when available.
Antibody specificity controls: Perform peptide competition assays by pre-incubating the antibody with excess synthetic peptide corresponding to the epitope.
Technical controls: Include secondary antibody-only controls to assess non-specific binding of the secondary antibody.
Loading controls: For quantitative Western blots, include established yeast housekeeping proteins (e.g., PGK1, TDH3) or total protein staining (Ponceau S) for normalization.
Positive controls: When available, include samples with tagged or overexpressed YDR230W as positive controls for antibody functionality.
Isotype controls: For immunoprecipitation experiments, include a matched isotype control antibody to distinguish specific from non-specific precipitation .
For accurate quantitative analysis of YDR230W expression, implement this methodological framework:
Normalization strategy: Normalize YDR230W signals to appropriate loading controls. For Western blots, use total protein normalization (stain-free gels or Ponceau S) rather than single housekeeping proteins, which may vary across conditions.
Dynamic range verification: Ensure measurements fall within the linear dynamic range of detection by performing standard curves with diluted samples.
Technical replication: Perform at least three technical replicates for each biological sample to account for technical variability in antibody performance.
Statistical approach: Apply appropriate statistical tests based on data distribution. For normally distributed data, use parametric tests (t-test, ANOVA); otherwise, use non-parametric alternatives.
Multiple method validation: Validate antibody-based quantification with orthogonal approaches such as qRT-PCR for mRNA levels or quantitative MS for protein levels.
Visualization standards: Present quantitative data with appropriate error bars (standard deviation or standard error) and p-values for statistical significance .